CoChat

Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score

Open access
Onengut-Gumuscu, Suna, Chen, Wei-Min, Robertson, Catherine C., Bonnie, Jessica K., Farber, Emily, Zhu, Zhennan, Oksenberg, Jorge R., Brant, Steven R., Bridges, S. Louis, Edberg, Jeffrey C., Kimberly, Robert P., Gregersen, Peter K., Rewers, Marian J., Steck, Andrea K., Black, Mary H., Dabelea, Dana, Pihoker, Catherine, Atkinson, Mark A., Wagenknecht, Lynne E., Divers, Jasmin, Bell, Ronny A., SEARCH for Diabetes in Youth, Type 1 Diabetes Genetics Consortium, Erlich, Henry A., Concannon, Patrick, Rich, Stephen S. · 2019 · Diabetes Care
Cited by 128

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Genetic risk scores (GRS) have been developed that differentiate individuals with type 1 diabetes from those with other forms of diabetes and are starting to be used for population screening; however, most studies were conducted in European-ancestry populations. This study identifies novel genetic variants associated with type 1 diabetes risk in African-ancestry participants and develops an African-specific GRS. RESEARCH DESIGN AND METHODS: We generated single nucleotide polymorphism (SNP) data with the ImmunoChip on 1,021 African-ancestry participants with type 1 diabetes and 2,928 control participants. HLA class I and class II alleles were imputed using SNP2HLA. Logistic regression models were used to identify genome-wide significant (P < 5.0 × 10−8) SNPs associated with type 1 diabetes in the African-ancestry samples and validate SNPs associated with risk in known European-ancestry loci (P < 2.79 × 10−5). RESULTS: African-specific (HLA-DQA1*03:01-HLA-DQB1*02:01) and known European-ancestry HLA haplotypes (HLA-DRB1*03:01-HLA-DQA1*05:01-HLA-DQB1*02:01, HLA-DRB1*04:01-HLA-DQA1*03:01-HLA-DQB1*03:02) were significantly associated with type 1 diabetes risk. Among European-ancestry defined non-HLA risk loci, six risk loci were significantly associated with type 1 diabetes in subjects of African ancestry. An African-specific GRS provided strong prediction of type 1 diabetes risk (area under the curve 0.871), performing significantly better than a European-based GRS and two polygenic risk scores in independent discovery and validation cohorts. CONCLUSIONS: Genetic risk of type 1 diabetes includes ancestry-specific, disease-associated variants. The GRS developed here provides improved prediction of type 1 diabetes in African-ancestry subjects and a means to identify groups of individuals who would benefit from immune monitoring for early detection of islet autoimmunity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc18-1727

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

Metadata

Authors
Onengut-Gumuscu, S., Chen, W.-M., Robertson, C. C., Bonnie, J. K., Farber, E., Zhu, Z., Oksenberg, J. R., Brant, S. R., Bridges, S. L., Edberg, J. C., Kimberly, R. P., Gregersen, P. K., Rewers, M. J., Steck, A. K., Black, M. H., Dabelea, D., Pihoker, C., Atkinson, M. A., Wagenknecht, L. E., Divers, J., Bell, R. A., Youth, S. F. D. I., Type 1 Diabetes Genetics Consortium, Erlich, H. A., Concannon, P., & Rich, S. S.
Venue
Diabetes Care
Published
2019-01-18
Volume
42
Issue
3
Pages
406-415
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2909528989
Cited by
128
References
12
FWCI
6.23
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.